Inhibitor Therapeutics, Inc.
INTI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,339 | -$3,026 | $12,106 | -$299 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $40 | $14 | $0 | $38 |
| Change in WC | $66 | $312 | $142 | $82 |
| Other Non-Cash | $0 | $0 | -$508 | -$42 |
| Operating Cash Flow | -$3,233 | -$2,700 | $11,741 | -$220 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$411 | $180 | $176 |
| Stock Issued | $0 | $0 | $0 | $200 |
| Stock Repurch. | $0 | $0 | $0 | -$176 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | -$411 | $180 | $176 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,233 | -$3,111 | $11,921 | -$44 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,840 | $11,951 | $31 | $75 |
| End Cash | $5,607 | $8,840 | $11,951 | $31 |
| Free Cash Flow | -$3,233 | -$2,700 | $11,741 | -$220 |